The Patented Medicine Prices Review Board (PMPRB), in accordance with sections 89 and 100 of the Patent Act, released its ... Read More
Events
01
Nov2017
31
Oct2017
PDCI is excited to announce another great addition to the PDCI team: John-Paul Dowson, Director, Reimbursement Strategy
/ PDCI, What's New
It is with great pleasure to announce after several months of a successful strategic partnership with Roubaix Strategies Inc. (RSI), ... Read More
30
Oct2017
We are pleased to announce that effective October 30, 2017 Jennifer Haig has joined PDCI Market Access Inc. as Manager, ... Read More
18
Oct2017
The Régie de l’assurance maladie du Québec (RAMQ) released its October update of the List of Medications on October 18, ... Read More
17
Oct2017
INESSS Releases Additional Information on the Continuous Evaluation of Drug Products – Mandatory Notification
/ INESSS, Quebec, What's New
On October 12, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers ... Read More
12
Oct2017
On October 11, 2017, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a new CDR Update ... Read More
11
Oct2017
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of September 30, 2017:
... Read More
29
Sep2017
The Hearing Panel of the Patented Medicine Prices Review Board has made public its decision in the matter of ... Read More